Judge Refuses To Toss Botox Marketing Class Action

Law360, New York (May 26, 2011, 6:13 PM EDT) -- A California federal judge on Wednesday largely preserved a putative class action accusing Allergan Inc. of improperly encouraging physicians to use a single vial of its blockbuster wrinkle-treating drug Botox for more than one patient without disclosing the alleged safety risks.

In several respects, U.S. District Judge Philip S. Gutierrez disagreed with Allergan that a sixth amended complaint filed by named plaintiff Dr. Ivan Goldsmith should be dismissed because its claimed violations of state False Advertising Law and Unfair Competition Law are insufficiently pled and because...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Ivan Goldsmith v. Allergan Inc.


Case Number

2:09-cv-07088

Court

California Central

Nature of Suit

Contract: Other

Judge

Philip S. Gutierrez

Date Filed

September 28, 2009

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.